New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Abnormal biomarkers associated with obesity identified in very young Latino children

Abnormal biomarkers associated with obesity identified in very young Latino children

Credit: Unsplash/CC0 Public DomainIn the United States, low-income, Latino youth are disproportionately affected by obesity, with 25.8% of Latino youth aged 2-19 considered to have obesity, which is a
Pediatrics April 01,2024
Abnormal biomarkers associated with obesity identified in very young Latino children

Abnormal biomarkers associated with obesity identified in very young Latino children

Credit: Unsplash/CC0 Public DomainIn the United States, low-income, Latino youth are disproportionately affected by obesity, with 25.8% of Latino youth aged 2-19 considered to have obesity, which is a
Pediatrics April 01,2024
P-glycoprotein removes Alzheimer's-associated toxin from the brain

P-glycoprotein removes Alzheimer's-associated toxin from the brain

by Southern Methodist University(A) The first frame of SMU's simulation shows amyloid-β bound to the drug binding domains of P-gp. (B) The final frame of the same simulation shows P-gp pushin
Neurology April 01,2024
P-glycoprotein removes Alzheimer's-associated toxin from the brain

P-glycoprotein removes Alzheimer's-associated toxin from the brain

by Southern Methodist University(A) The first frame of SMU's simulation shows amyloid-β bound to the drug binding domains of P-gp. (B) The final frame of the same simulation shows P-gp pushin
Neurology April 01,2024
MRI's may be initial window into CTE diagnosis in living; approach may shave years off diagnosis

MRI's may be initial window into CTE diagnosis in living; approach may shave years off diagnosis

by Boston University School of MedicineCredit: Pixabay/CC0 Public DomainWhile chronic traumatic encephalopathy (CTE) cannot yet be diagnosed during life, a new study provides the best evidence to
Neurology April 01,2024
MRI's may be initial window into CTE diagnosis in living; approach may shave years off diagnosis

MRI's may be initial window into CTE diagnosis in living; approach may shave years off diagnosis

by Boston University School of MedicineCredit: Pixabay/CC0 Public DomainWhile chronic traumatic encephalopathy (CTE) cannot yet be diagnosed during life, a new study provides the best evidence to
Neurology April 01,2024
Reducing dementia risks

Reducing dementia risks

by Deb BalzerCredit: Pixabay/CC0 Public DomainFormer first lady Rosalynn Carter has been diagnosed with dementia. A family statement, posted on The Carter Center website, says that she continues to li
Neurology April 01,2024
Reducing dementia risks

Reducing dementia risks

by Deb BalzerCredit: Pixabay/CC0 Public DomainFormer first lady Rosalynn Carter has been diagnosed with dementia. A family statement, posted on The Carter Center website, says that she continues to li
Neurology April 01,2024
Metabolism linked to brain health

Metabolism linked to brain health

by University of South AustraliaCredit: MART PRODUCTION from PexelsEvery three seconds, someone in the world is diagnosed with dementia. And while there is no known cure, changes in the brain can
Neurology April 01,2024
Metabolism linked to brain health

Metabolism linked to brain health

by University of South AustraliaCredit: MART PRODUCTION from PexelsEvery three seconds, someone in the world is diagnosed with dementia. And while there is no known cure, changes in the brain can
Neurology April 01,2024
Mindset4Dementia app uses AI for next generation screening tool

Mindset4Dementia app uses AI for next generation screening tool

by Kate Clark,University College LondonCredit: Pixabay/CC0 Public DomainA team of students and doctors, led by UCL medic Hamzah Selim, has launched an innovative app which uses fun brain games t
Neurology April 01,2024
Mindset4Dementia app uses AI for next generation screening tool

Mindset4Dementia app uses AI for next generation screening tool

by Kate Clark,University College LondonCredit: Pixabay/CC0 Public DomainA team of students and doctors, led by UCL medic Hamzah Selim, has launched an innovative app which uses fun brain games t
Neurology April 01,2024
Molecular tracer, seen with PET scan, shows concentrations of abnormal proteins

Molecular tracer, seen with PET scan, shows concentrations of abnormal proteins

by University of California, Los AngelesResearchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encep
Neurology April 01,2024
Molecular tracer, seen with PET scan, shows concentrations of abnormal proteins

Molecular tracer, seen with PET scan, shows concentrations of abnormal proteins

by University of California, Los AngelesResearchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encep
Neurology April 01,2024
PET tracer gauges effectiveness of promising Alzheimer's treatment

PET tracer gauges effectiveness of promising Alzheimer's treatment

by Society of Nuclear Medicine and Molecular ImagingPET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observ
Neurology April 01,2024
PET tracer gauges effectiveness of promising Alzheimer's treatment

PET tracer gauges effectiveness of promising Alzheimer's treatment

by Society of Nuclear Medicine and Molecular ImagingPET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observ
Neurology April 01,2024
Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement
Neurology April 01,2024
Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement
Neurology April 01,2024
PET points to tau protein as leading culprit in Alzheimer's

PET points to tau protein as leading culprit in Alzheimer's

by Society of Nuclear MedicineTopographical correspondence of tau- but not amyloid-pathology with neuronal dysfunction in Alzheimer's disease. Right lateral surface of projected z-score image
Neurology April 01,2024
PET points to tau protein as leading culprit in Alzheimer's

PET points to tau protein as leading culprit in Alzheimer's

by Society of Nuclear MedicineTopographical correspondence of tau- but not amyloid-pathology with neuronal dysfunction in Alzheimer's disease. Right lateral surface of projected z-score image
Neurology April 01,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com